Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Emond

Showing results (191-200 of 214) with videos related to

Pageof 22
Sort By:
Transplantation|May 18, 2017
Hepatic Hemodynamics and Portal Flow Modulation: The A2ALL ExperienceJean C Emond, Nathan P Goodrich, James J Pomposelli, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 4, 2008
Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort StudyC E Freise, B W Gillespie, A J Koffron, et al.
Clinical Transplantation|September 17, 2013
Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicityJeffrey Campsen, Michael Zimmerman, James Trotter, et al.
Annals of Surgery|September 2, 2005
Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL ConsortiumKim M Olthoff, Robert M Merion, Rafik M Ghobrial, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 21, 2016
Social and Financial Outcomes of Living Liver Donation: A Prospective Investigation Within the Adult-to-Adult Living Donor Liver Transplantation Cohort Study 2 (A2ALL-2)A DiMartini, M A Dew, Q Liu, et al.
The Journal of Experimental Medicine|February 9, 2005
RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaBGuellue Cataldegirmen, Shan Zeng, Nikki Feirt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 18, 2020
Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort studyMarcus R Pereira, Meghan M Aversa, Maryjane A Farr, et al.
JAMA Surgery|July 20, 2022
Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular CarcinomaParissa Tabrizian, Matthew L Holzner, Neil Mehta, et al.
Transplantation|May 7, 2016
Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort StudyMary Amanda Dew, Andrea F DiMartini, Daniela P Ladner, et al.
Gastroenterology|April 17, 2012
Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centersSarwa Darwish Murad, W Ray Kim, Denise M Harnois, et al.
Pageof 22

Showing results (191-200 of 214) with videos related to

Sort By:
Pageof 22
Transplantation|May 18, 2017
Hepatic Hemodynamics and Portal Flow Modulation: The A2ALL ExperienceJean C Emond, Nathan P Goodrich, James J Pomposelli, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 4, 2008
Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort StudyC E Freise, B W Gillespie, A J Koffron, et al.
Clinical Transplantation|September 17, 2013
Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicityJeffrey Campsen, Michael Zimmerman, James Trotter, et al.
Annals of Surgery|September 2, 2005
Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL ConsortiumKim M Olthoff, Robert M Merion, Rafik M Ghobrial, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 21, 2016
Social and Financial Outcomes of Living Liver Donation: A Prospective Investigation Within the Adult-to-Adult Living Donor Liver Transplantation Cohort Study 2 (A2ALL-2)A DiMartini, M A Dew, Q Liu, et al.
The Journal of Experimental Medicine|February 9, 2005
RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaBGuellue Cataldegirmen, Shan Zeng, Nikki Feirt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 18, 2020
Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort studyMarcus R Pereira, Meghan M Aversa, Maryjane A Farr, et al.
JAMA Surgery|July 20, 2022
Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular CarcinomaParissa Tabrizian, Matthew L Holzner, Neil Mehta, et al.
Transplantation|May 7, 2016
Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort StudyMary Amanda Dew, Andrea F DiMartini, Daniela P Ladner, et al.
Gastroenterology|April 17, 2012
Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centersSarwa Darwish Murad, W Ray Kim, Denise M Harnois, et al.
Pageof 22